STOCK TITAN
  1. Home
  2. Sec-filings
  3. PGEN
  4. [Form 4] Precigen, Inc. Insider Trading Activity

Precigen Strengthens Executive Retention with Major Stock Award to Legal Chief

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Donald P. Lehr, Chief Legal Officer of Precigen (PGEN), reported receiving 125,000 Restricted Stock Units (RSUs) on June 26, 2025. Each RSU represents a contingent right to receive one share of Precigen common stock.

The RSUs follow a specific vesting schedule: 50% will vest on May 23, 2026, with the remaining portion vesting in equal monthly installments over the subsequent three years. The RSUs were granted at no cost ($0) to the executive.

This equity compensation grant aligns the legal officer's interests with shareholders through long-term vesting requirements. The transaction was reported via Form 4 within the required reporting timeframe, with the filing made on June 28, 2025.

Positive

  • Chief Legal Officer received 125,000 RSUs with long-term vesting schedule (4 years), promoting retention and alignment with shareholder interests

Negative

  • None.
Insider Lehr Donald P.
Role Chief Legal Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units 125,000 $0.00 --
Holdings After Transaction: Restricted Stock Units — 125,000 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lehr Donald P.
(Last) (First) (Middle)
20374 SENECA MEADOWS PARKWAY
(Street)
GERMANTOWN MD 20876
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 06/26/2025 A 125,000 (2) (2) Common Stock 125,000 $0 125,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
2. The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter.
/s/ Donald P. Lehr 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What is the vesting schedule for PGEN CLO Donald Lehr's new RSU grant?

The RSUs granted to Donald Lehr vest 50% on May 23, 2026, with the remaining 50% vesting in equal monthly installments over the following three years.

What was the exercise price of PGEN's RSUs granted to Donald Lehr?

The RSUs were granted at $0 exercise price, as they represent a contingent right to receive Precigen common stock upon vesting rather than an option to purchase shares.

Who filed Form 4 for PGEN on June 28, 2025?

Donald P. Lehr, PGEN's Chief Legal Officer, filed the Form 4. The filing was made to report his receipt of 125,000 RSUs and was signed by him on June 27, 2025.

What is Donald Lehr's role at PGEN according to the Form 4?

According to the Form 4 filing, Donald P. Lehr serves as the Chief Legal Officer of Precigen, Inc. (PGEN). This is indicated in Section 5 of the form where his relationship to the issuer is marked as an Officer with the title 'Chief Legal Officer.'